Cancer driver topologically associated domains identify oncogenic and tumor-suppressive lncRNAs

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 6.
Figure 6.

Depletion of the identified putative cancer driver lncRNAs increases or decreases the wound closure rate of prostate cancer cells. Wound healing assay of PC-3 prostate cancer cells with each putative oncogenic lncRNA (A) or tumor-suppressive lncRNA (B) disrupted by CRISPR-Cas9 guide RNA p1, p2, or under control condition.

This Article

  1. Published in Advance May 27, 2025, doi: 10.1101/gr.280235.124 Genome Res. 35: 1842-1858

Preprint Server



Current Issue

  1. March 2026, 36 (3)
  1. Current Issue
  1. Alert me to new issues of Genome Research